Gilead Sciences (GILD)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Gilead Sciences | GILD | Healthcare | Drug Manufacturers - General | 43 | 7.3% |
| Current Price (11/27 4:00PM EST) | $74.92 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 27,382.0 | |||
| Sales Growth Forecast | 0.5% | |||
| Net Profit Margin | 27.6% | |||
| Projected Shares Outstanding | 1,234.96 | |||
| EPS - Five year Forecast | $6.28 | |||
| Average P/E Ratio | 14.0 | |||
| Projected Average Price | $87.87 | |||
| Price Appreciation (Annualized) | 3.2% | |||
| Annual Dividend Yield | 4.1% | |||
| Projected Annual Return | 7.3% | |||
| Quality | ||||
| Financial Strength | 39 | 9.9 | ||
| EPS Stability | 48 | 12.0 | ||
| Industry Sales Growth Rate | 4.0% | 1.6 | ||
| Industry Net Profit Margin | 19.3% | 17.9 | ||
| Calculated Quality Rating | 41.3 | |||
| Fool CAPS | ||||
Total Players
3341
Outperforms
91
Underperforms
All-Stars (598)
589
Outperforms (98%)
9
Underperforms
|
||||
| Fundamental Data Updated: 06/30/2023 | ||||